These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2207329)

  • 1. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.
    Day KC; Hoffman LC; Palmier MO; Kretzmer KK; Huang MD; Pyla EY; Spokas E; Broze GJ; Warren TG; Wun TC
    Blood; 1990 Oct; 76(8):1538-45. PubMed ID: 2207329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
    Wun TC
    Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
    Kouz J; Czech J; Nicolay U; Dickneite G
    Haemostasis; 1996; 26(4):179-86. PubMed ID: 8872128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.
    Warr TA; Rao LV; Rapaport SI
    Blood; 1990 Apr; 75(7):1481-9. PubMed ID: 2317559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.
    Sandset PM; Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):708-12. PubMed ID: 1899482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant properties of rabbit lungs in tissue thromboplastin-induced intravascular coagulation.
    Vad H; Tvedskov TF; Hansen KB; Albrechtsen OK; Jespersen J; Gram J
    Thromb Haemost; 1997 Apr; 77(4):679-84. PubMed ID: 9134642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):629-35. PubMed ID: 1664252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction.
    Sandset PM; Warn-Cramer BJ; Maki SL; Rapaport SI
    Blood; 1991 Sep; 78(6):1496-502. PubMed ID: 1909195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
    Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
    Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.
    Haskel EJ; Torr SR; Day KC; Palmier MO; Wun TC; Sobel BE; Abendschein DR
    Circulation; 1991 Aug; 84(2):821-7. PubMed ID: 1860224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.